HCA Healthcare (NYSE:HCA) Updates FY 2024 Earnings Guidance

HCA Healthcare (NYSE:HCA) updated its FY 2024 earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of 21.600-22.800 for the period, compared to the consensus estimate of 20.980. The company issued revenue guidance of $69.8 billion-$71.8 billion, compared to the consensus revenue estimate of $69.8 billion.

Analysts Set New Price Targets

A number of brokerages have recently commented on HCA. TD Cowen lowered their price target on HCA Healthcare from $371.00 to $360.00 and set a buy rating for the company in a research note on Tuesday, April 30th. Oppenheimer upped their price target on HCA Healthcare from $345.00 to $390.00 and gave the company an outperform rating in a research note on Wednesday. Truist Financial upped their price target on HCA Healthcare from $375.00 to $390.00 and gave the company a buy rating in a research note on Wednesday. Cantor Fitzgerald reaffirmed an overweight rating and issued a $335.00 price target on shares of HCA Healthcare in a research note on Wednesday. Finally, Deutsche Bank Aktiengesellschaft increased their target price on HCA Healthcare from $359.00 to $375.00 and gave the stock a buy rating in a research note on Friday, June 28th. Four equities research analysts have rated the stock with a hold rating, fourteen have given a buy rating and two have given a strong buy rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of Moderate Buy and an average price target of $339.72.

HCA Healthcare Stock Performance

HCA stock traded up $9.25 during trading hours on Thursday, hitting $353.19. 568,252 shares of the stock were exchanged, compared to its average volume of 1,148,371. The company has a current ratio of 1.16, a quick ratio of 1.02 and a debt-to-equity ratio of 29.26. The firm has a market capitalization of $92.50 billion, a P/E ratio of 17.15, a P/E/G ratio of 1.45 and a beta of 1.68. The company has a 50-day simple moving average of $328.88 and a two-hundred day simple moving average of $322.41. HCA Healthcare has a 12 month low of $215.96 and a 12 month high of $355.88.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Tuesday, July 23rd. The company reported $5.50 EPS for the quarter, topping analysts’ consensus estimates of $4.97 by $0.53. HCA Healthcare had a return on equity of 621.57% and a net margin of 8.40%. The company had revenue of $17.49 billion for the quarter, compared to analysts’ expectations of $17.05 billion. During the same quarter last year, the business earned $4.29 earnings per share. HCA Healthcare’s revenue was up 10.3% on a year-over-year basis. On average, analysts forecast that HCA Healthcare will post 22.2 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Monday, September 30th. Shareholders of record on Monday, September 16th will be given a $0.66 dividend. This represents a $2.64 dividend on an annualized basis and a yield of 0.75%. The ex-dividend date of this dividend is Monday, September 16th. HCA Healthcare’s dividend payout ratio is presently 13.16%.

Insider Buying and Selling

In other HCA Healthcare news, SVP Kathryn A. Torres sold 973 shares of HCA Healthcare stock in a transaction that occurred on Thursday, May 2nd. The stock was sold at an average price of $312.00, for a total value of $303,576.00. Following the completion of the sale, the senior vice president now directly owns 22,365 shares in the company, valued at $6,977,880. The sale was disclosed in a filing with the SEC, which is available at the SEC website. In other news, SVP Kathryn A. Torres sold 1,863 shares of the business’s stock in a transaction that occurred on Wednesday, May 15th. The stock was sold at an average price of $326.18, for a total transaction of $607,673.34. Following the completion of the sale, the senior vice president now owns 19,612 shares in the company, valued at $6,397,042.16. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, SVP Kathryn A. Torres sold 973 shares of the company’s stock in a transaction on Thursday, May 2nd. The stock was sold at an average price of $312.00, for a total value of $303,576.00. Following the sale, the senior vice president now owns 22,365 shares of the company’s stock, valued at approximately $6,977,880. The disclosure for this sale can be found here. Insiders have sold a total of 12,397 shares of company stock valued at $3,921,929 over the last ninety days. 1.60% of the stock is owned by company insiders.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.